Trial · NCT01147822
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Progression-free Survival (PFS) | Pazopanib 800 mg | 8.4 | 95% Confidence Interval 8.3 to 11.1 | Months | |
| Progression-free Survival (PFS) | Sunitinib 50 mg | 11.1 | 95% Confidence Interval 8.2 to 14.3 | Months | |
| Overall Survival (OS) | Pazopanib 800 mg | 26.7 | 95% Confidence Interval 23.7 to 41.7 | Months | |
| Overall Survival (OS) | Sunitinib 50 mg | 33.4 | 95% Confidence Interval 26.9 to 39.6 | Months | |
| Overall Response Rate (ORR) as Assessed by Independent Review | Pazopanib 800 mg | 36 | 95% Confidence Interval 28.8 to 42.5 | Percentage of Participants | |
| Overall Response Rate (ORR) as Assessed by Independent Review | Sunitinib 50 mg | 21 | 95% Confidence Interval 14.7 to 26.6 | Percentage of Participants | |
| Time to Response | Pazopanib 800 mg | 11.9 | 95% Confidence Interval 6.7 to 12.3 | Weeks | |
| Time to Response | Sunitinib 50 mg | 17.9 | 95% Confidence Interval 12.0 to 23.9 | Weeks | |
| Duration of Response (DOR) | Pazopanib 800 mg | 15.2 | 95% Confidence Interval 9.9 to 17.9 | Months | |
| Duration of Response (DOR) | Sunitinib 50 mg | 18.0 | 95% Confidence Interval 12.3 to NA | Months | |
| All Collected Deaths | Pazopanib 800 mg | Pre-treatment deaths | 0 | Participants | |
| All Collected Deaths | Sunitinib 50 mg | Pre-treatment deaths | 0 | Participants | |
| All Collected Deaths | Pazopanib 800 mg | On-treatment deaths | 7 | Participants | |
| All Collected Deaths | Sunitinib 50 mg | On-treatment deaths | 6 | Participants | |
| All Collected Deaths | Pazopanib 800 mg | Post-treatment deaths | 92 | Participants | |
| All Collected Deaths | Sunitinib 50 mg | Post-treatment deaths | 80 | Participants | |
| All Collected Deaths | Pazopanib 800 mg | All deaths | 99 | Participants | |
| All Collected Deaths | Sunitinib 50 mg | All deaths | 86 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01147822/results